Testosterone Cypionate vs NHS TRT: Comparing Your Options in the UK

If you have been diagnosed with low testosterone or suspect you have it, one of the first decisions you face is how to access treatment. The NHS offers testosterone replacement therapy through a defined set of licensed preparations. Private clinics and specialist UK suppliers offer testosterone cypionate, which is the most commonly prescribed ester in the United States but remains outside the standard NHS formulary. This guide from Hemi Pharma UK compares every NHS testosterone option against testosterone cypionate on pharmacokinetics, convenience, cost, and real-world user experience, so you can make an informed choice about which route is right for you.

Key Takeaways

  • The NHS primarily prescribes three testosterone preparations: Sustanon 250 (mixed ester injection every 2 to 4 weeks), Nebido (long-acting injection every 10 to 14 weeks), and testosterone gel (daily transdermal application). Testosterone cypionate is not on the standard NHS Drug Tariff but can be prescribed as an unlicensed medicine.
  • Testosterone cypionate’s 8-day half-life supports the most stable serum levels of any commonly available injectable ester when administered weekly or twice weekly, outperforming Sustanon 250’s mixed-ester peaks and Nebido’s prolonged troughs.
  • NHS TRT costs the standard prescription charge (£9.90 per item). Private testosterone cypionate TRT through a clinic costs £100 to £250 per month including bloods and consultations. Self-managed testosterone cypionate with private blood work costs less but requires personal responsibility for monitoring.
  • The average NHS waiting time from GP referral to endocrinology appointment is 12 to 26 weeks. Private TRT clinics typically start treatment within 1 to 2 weeks of initial consultation.
  • Switching from NHS TRT to testosterone cypionate does not require weaning or tapering. You simply replace one testosterone preparation with another at an equivalent dose, guided by blood work.

What Testosterone Options Does the NHS Prescribe?

The NHS formulary for male hypogonadism includes a limited set of MHRA-licensed testosterone preparations. Understanding what each one offers helps clarify why many men seek testosterone cypionate as an alternative.

Preparation Active Esters Route Typical Dose Frequency Half-Life NHS Drug Tariff Cost (approx)
Sustanon 250 Propionate 30mg, Phenylpropionate 60mg, Isocaproate 60mg, Decanoate 100mg Intramuscular injection 250mg per ampoule Every 2 to 4 weeks Variable (shortest ~2 days, longest ~15 days) ~£3 to £5 per ampoule
Nebido (Testosterone Undecanoate) Undecanoate 1000mg/4mL Intramuscular injection (slow, deep gluteal) 1000mg per injection Every 10 to 14 weeks (after loading) ~21 to 34 days ~£80 to £90 per ampoule
Testogel / Tostran (Gel) Testosterone (no ester) Transdermal (skin application) 40 to 80mg daily (gel dependent) Daily ~10 hours (requires daily application) ~£30 to £45 per month
Testosterone Cypionate (not standard NHS) Cypionate 200 or 250mg/mL Intramuscular or subcutaneous injection 100 to 200mg weekly Weekly or twice weekly ~8 days Not on NHS Drug Tariff (available as unlicensed medicine or private supply)

Why Is Testosterone Cypionate Not Standard on the NHS?

This is a regulatory and formulary issue, not a clinical one. Testosterone cypionate does not currently hold a UK marketing authorisation (MHRA licence) under the common brand names. In the United States, Depo-Testosterone (testosterone cypionate) has been FDA-approved and the most prescribed testosterone ester for decades. In the UK, Sustanon 250 and Nebido secured MHRA licences first and became the standard formulary options, while testosterone cypionate remained unlicensed for the UK market.

An unlicensed medicine can still be prescribed by any UK doctor under their clinical responsibility, but the prescribing pathway is more complex. The prescriber must take personal accountability, justify why a licensed alternative is unsuitable, and source the product through a specials manufacturer or importation pathway. Most NHS GPs are unfamiliar with this process and default to the formulary options they know. A study of UK testosterone prescribing patterns published in Clinical Endocrinology documented a significant increase in testosterone prescriptions between 2001 and 2010, with Sustanon 250 and Nebido dominating the prescribing data. Testosterone cypionate was not a meaningful contributor to NHS prescriptions during this period.

This licensing gap is purely administrative. There is no clinical evidence suggesting testosterone cypionate is inferior to Sustanon 250 or Nebido. In fact, the pharmacokinetic data suggests the opposite: testosterone cypionate produces more stable serum levels than Sustanon on equivalent injection schedules, and far more flexible dosing than Nebido.

How Does Testosterone Cypionate Compare to Sustanon 250?

Sustanon 250 is the most commonly prescribed injectable testosterone in the NHS. It contains four testosterone esters with different release rates, designed to provide both a rapid onset (from the propionate and phenylpropionate) and sustained effect (from the isocaproate and decanoate).

In theory, this mixed-ester approach should produce stable levels. In practice, the pharmacokinetic reality is more complex. The different esters peak at different times, creating multiple peaks and troughs within each dosing interval. Many users on Sustanon 250 at the standard NHS schedule of one ampoule every 3 to 4 weeks report a familiar pattern: feeling excellent for the first week, gradual decline in the second and third weeks, and clear symptoms of low testosterone (fatigue, low libido, irritability) before the next injection.

Factor Sustanon 250 (NHS standard) Testosterone Cypionate
Injection frequency Every 2 to 4 weeks (NHS standard) Weekly or twice weekly
Serum level stability Poor on 3 to 4 week schedule; multiple peaks from mixed esters Excellent on twice-weekly schedule; single ester, predictable curve
Peak-to-trough variation Very high on standard schedule Low on twice-weekly; moderate on weekly
Self-injection suitability Glass ampoule; requires breaking and drawing; single-use Multi-use vial; more convenient for frequent self-injection
Dose flexibility Fixed 250mg ampoule; difficult to split accurately Precise dosing from multi-use vial with syringe graduation
Oestradiol management Higher peaks mean more aromatisation; E2 harder to control Lower peaks with split dosing; E2 management simpler
NHS availability Standard formulary; widely stocked Not on Drug Tariff; unlicensed or private supply

The fundamental advantage of testosterone cypionate over Sustanon 250 is dosing flexibility and level stability. A multi-use vial of testosterone cypionate 200mg/mL allows precise dose titration (125mg, 150mg, 175mg, or any other amount) using standard syringes, split across multiple injections per week. Sustanon 250 comes in a single-use glass ampoule that is difficult to split accurately and does not lend itself to the frequent, smaller injections that produce the most stable blood levels.

How Does Testosterone Cypionate Compare to Nebido?

Nebido (testosterone undecanoate 1000mg/4mL) is the NHS’s long-acting option. A single injection is administered every 10 to 14 weeks, which means the patient visits their GP surgery as infrequently as four to five times per year for testosterone treatment.

Factor Nebido Testosterone Cypionate
Injection frequency Every 10 to 14 weeks Weekly or twice weekly (self-administered)
Injection volume 4mL (large, deep gluteal injection; often painful) 0.5 to 1.25mL per injection (small, comfortable)
Self-injection Typically administered by healthcare professional; difficult to self-inject due to volume Easy to self-inject IM or SC
Dose titration speed Very slow: 3 to 4 months per dose adjustment cycle Fast: 6 weeks to new steady state; responsive to adjustments
Pre-injection trough Can drop to hypogonadal levels in last 2 to 4 weeks before next injection Trough remains within therapeutic range on weekly schedule
NHS availability Standard formulary; higher Drug Tariff cost (~£80 to £90) Not on Drug Tariff

Nebido’s advantage is convenience for patients who do not want to self-inject. Its disadvantages are the large injection volume (4mL is a significant intramuscular depot), the very slow dose titration (each adjustment requires waiting 10 to 14 weeks to see the effect), and the pre-injection trough that leaves many patients symptomatic for weeks before their next appointment. The week-by-week timeline shows how testosterone cypionate maintains consistent levels throughout each dosing interval, avoiding the symptomatic troughs that Nebido users frequently report.

How Does Testosterone Cypionate Compare to Testosterone Gel?

Testosterone gel (Testogel, Tostran) is the NHS’s transdermal option. It is applied daily to the skin (usually upper arms, shoulders, or abdomen), where testosterone absorbs through the epidermis into the bloodstream.

Factor Testosterone Gel Testosterone Cypionate
Application Daily skin application; 3 to 5 minute drying time Injection once or twice weekly
Transfer risk Significant: skin-to-skin contact can transfer testosterone to partners, children, and pets None: injected directly; no transfer risk
Absorption variability High: sweating, showering, skin type, application site all affect absorption Low: injection delivers a precise dose regardless of external factors
Serum levels achieved Often subtherapeutic: many men cannot absorb enough through the skin Predictable and dose-dependent
Convenience No needles; but requires daily application and strict transfer precautions Needles required; but only once or twice weekly
Cost (NHS) ~£30 to £45/month Drug Tariff; frequent prescriptions needed Not on Drug Tariff

The transfer risk of testosterone gel is a serious clinical concern. The partner education guide and safety around testosterone users guide cover this issue in detail. FDA safety communications have documented cases of virilisation in children and female partners from skin-to-skin contact with gel users, including accelerated bone maturation, premature pubic hair development, and genital enlargement. Injectable testosterone cypionate eliminates this risk entirely.

What Are the Full Costs of NHS TRT vs Testosterone Cypionate?

Route Monthly Cost (to patient) Includes Waiting Time to Start Product Choice
NHS (prescription) £9.90 per item (standard charge) or free if exempt Testosterone only; blood work covered by NHS; GP monitoring 12 to 26 weeks (referral to endocrinology) Limited: Sustanon, Nebido, or gel (GP’s choice from formulary)
Private TRT clinic £100 to £250 Testosterone (usually cypionate or enanthate), blood work, consultations, protocol adjustments 1 to 2 weeks Full: cypionate, enanthate, or patient preference
Self-managed with private bloods Varies (testosterone + £50 to £150 per blood panel) Testosterone only; blood work self-arranged; no medical oversight unless sought Immediate (legal for personal possession) Full: user selects product and supplier

The NHS route is the most affordable but offers the least flexibility in product choice, the longest waiting times, and often the least responsive dose titration. Private clinics offer the best combination of speed, product choice, and medical oversight, at a higher monthly cost. Self-managed use offers maximum flexibility and lowest cost but requires personal responsibility for blood work monitoring and protocol management.

What Are the Most Common NHS TRT Frustrations That Testosterone Cypionate Solves?

Users who switch from NHS TRT to testosterone cypionate consistently cite the same set of frustrations that the switch resolved.

The most frequent is the peak-and-trough rollercoaster. On Sustanon 250 every 3 to 4 weeks, or Nebido every 10 to 14 weeks, many men describe a pattern of feeling good for the first portion of the dosing interval, then progressively worse as levels decline toward the next injection. This is not psychological; it is pharmacokinetic reality. The depression research and anxiety research both document how hormone fluctuations affect mood. Testosterone cypionate on a twice-weekly schedule eliminates this pattern by maintaining levels within a narrow, stable band throughout the dosing interval.

The second frustration is inflexible dosing. NHS prescriptions are typically for a fixed dose of a fixed preparation (one ampoule of Sustanon, one vial of Nebido). If you need a dose adjustment, it requires a GP appointment, a prescription change, and often weeks of waiting. With testosterone cypionate from a multi-use vial, you adjust your own dose by drawing a different volume, confirmed by follow-up blood work.

The third is the lack of self-injection convenience. Sustanon ampoules are glass, single-use, and require breaking open. Nebido is typically administered by a nurse at the GP surgery, requiring an appointment. Testosterone cypionate from a multi-use vial with a rubber stopper is designed for repeated, convenient self-injection at home, on your own schedule.

The fourth is the GP’s reluctance to optimise. Many NHS GPs consider TRT “successful” if testosterone is “somewhere within the reference range,” even if the patient’s trough is barely above the lower limit and they remain symptomatic. Private and self-managed protocols target upper-normal trough levels (20 to 30 nmol/L), which is where most men report the best symptom resolution. The confidence research and cognitive clarity research both support the clinical relevance of optimised versus merely adequate levels.

How Do You Switch from NHS TRT to Testosterone Cypionate?

Switching from an NHS testosterone preparation to testosterone cypionate is straightforward from a pharmacological perspective. You are replacing one testosterone ester with another; no tapering, weaning, or washout period is required.

If you are switching from Sustanon 250 (250mg every 3 weeks, which delivers approximately 83mg per week), a starting dose of 100mg weekly of testosterone cypionate 200mg is a reasonable equivalent, adjusted based on blood work at 6 to 8 weeks. If switching from Nebido (1000mg every 12 weeks, approximately 119mg per week), 125mg weekly of testosterone cypionate is a reasonable starting point.

If switching from testosterone gel, the equivalent injectable dose is harder to calculate because gel absorption is variable. Start with 100mg weekly of testosterone cypionate and assess blood work at 6 weeks. Many men who “failed” on gel (did not achieve adequate serum levels despite maximum gel dose) find that injectable testosterone cypionate at a modest dose produces the therapeutic levels they never achieved transdermally.

Inform your GP of the switch. The GP communication guide covers how to discuss this transition productively. Many GPs are willing to continue monitoring blood work even when the patient has moved to a private or self-managed testosterone cypionate protocol, because the monitoring requirement does not change with the product.

Can Your GP Prescribe Testosterone Cypionate on the NHS?

Yes, but it requires the GP to prescribe it as an unlicensed or “specials” medicine under their clinical responsibility. This means the GP must justify why a licensed alternative is unsuitable (for example, the patient experienced unacceptable peaks and troughs on Sustanon, did not absorb gel adequately, or could not tolerate Nebido injections), and take personal clinical accountability for the prescription.

Some GPs will do this readily, particularly if you can present a clear clinical rationale supported by blood work showing suboptimal levels on your current preparation. Others are unwilling to prescribe outside the formulary, regardless of the clinical reasoning. The BSSM 2023 guidelines recommend that treatment choice should be a shared decision between prescriber and patient, taking into account the patient’s preference, lifestyle, and treatment response. If your GP declines, a private TRT clinic can prescribe testosterone cypionate directly and write to your GP requesting shared-care monitoring.

Frequently Asked Questions

Is testosterone cypionate better than Sustanon for TRT?

Pharmacokinetically, yes. Testosterone cypionate’s single-ester, 8-day half-life produces more stable serum levels on weekly or twice-weekly injection than Sustanon 250’s mixed-ester profile on the standard NHS schedule of every 2 to 4 weeks. The result is less peak-to-trough variation, fewer oestradiol spikes, fewer mood and energy fluctuations, and easier side effect management. The clinical evidence for both preparations achieving adequate testosterone levels is comparable; the difference is in the quality of the pharmacokinetic profile.

Can I get testosterone cypionate on the NHS for free?

If you have an NHS exemption certificate (medical exemption, universal credit, over 60, etc.), your NHS prescriptions are free. Testosterone cypionate can be prescribed as an unlicensed medicine by your GP, but most GPs default to formulary options (Sustanon, Nebido, gel). If your GP agrees to prescribe testosterone cypionate, it would be dispensed at no charge under your exemption.

How long does it take to start TRT on the NHS vs privately?

NHS: typically 12 to 26 weeks from GP referral to endocrinology appointment, plus time for diagnostic blood work and treatment initiation. Private TRT clinic: typically 1 to 2 weeks from initial consultation to starting treatment, including blood work. Self-managed: immediate, since testosterone cypionate is legal to possess for personal use in the UK.

Is NHS TRT good enough or do I need private testosterone cypionate?

NHS TRT is clinically adequate for many men. Sustanon, Nebido, and gel all achieve therapeutic testosterone levels in a significant proportion of patients. However, many men experience suboptimal results on NHS preparations due to the peak-and-trough cycles of infrequent Sustanon injections, the prolonged troughs before Nebido redosing, or poor absorption from gel. If you are symptomatic despite being on NHS TRT with blood work showing adequate trough levels, your preparation may not be the issue. If blood work shows inadequate trough levels despite maximum doses, switching to testosterone cypionate with more frequent injection may resolve the problem.

Will my GP still monitor my blood work if I switch to private testosterone cypionate?

Many GPs will continue monitoring if asked, because the blood work requirements (testosterone, haematocrit, PSA, lipids) are the same regardless of the testosterone source. Some GPs may decline on principle if you are using testosterone outside a prescription. The GP communication guide and the blood work guide cover both scenarios.

References

Gan, E.H., Pattman, S., Pearce, S.H.S. and Quinton, R. (2013) ‘A UK epidemic of testosterone prescribing, 2001-2010’, Clinical Endocrinology, 79(4), pp. 564-570. Available at: https://pubmed.ncbi.nlm.nih.gov/23581479/ (Accessed: 6 November 2026).

Hackett, G., Kirby, M., Edwards, D., Jones, T.H., Wylie, K., Ossei-Gerning, N., David, J. and Muneer, A. (2023) ‘The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice’, World Journal of Men’s Health, 41(3), pp. 508-537. Available at: https://pubmed.ncbi.nlm.nih.gov/36876744/ (Accessed: 6 November 2026).

Bhasin, S., Brito, J.P., Cunningham, G.R., Hayes, F.J., Hodis, H.N., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., Wu, F.C. and Yialamas, M.A. (2018) ‘Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline’, Journal of Clinical Endocrinology and Metabolism, 103(5), pp. 1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/29562364/ (Accessed: 6 November 2026).

BSW Area Prescribing Committee (2025) Testosterone in Men: Prescribing Guideline, v0.9. Bath and North East Somerset, Swindon and Wiltshire ICB. Available at: https://bswtogether.org.uk/medicines/ (Accessed: 6 November 2026).

Shopping Basket
Scroll to Top